Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 6Recurrence 2Neoplasms, Plasma Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Burkitt Lymphoma 2Meningeal Carcinomatosis 1Lymphoma 1Lymphedema 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Disease Progression 1Disease 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Cytarabine 16Arsenic Trioxide 11Tretinoin 10Methotrexate 10Cyclophosphamide 9Idarubicin 8Filgrastim 7Mercaptopurine 6Busulfan 6fludarabine phosphate 5Etoposide 5Vorinostat 4Topotecan 4Sorafenib 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Daunorubicin 4Clofarabine 4Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3Azacitidine 3Antilymphocyte Serum 3romidepsin 2merphos 2lintuzumab 2entinostat 2Thiotepa 2Tacrolimus 2Mitoxantrone 2Lenalidomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Promyelocytic, Acute × Transplantation, Autologous × Clear all
NCT00504764 2014-10-28

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

PETHEMA Foundation

Phase 4 Completed
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡